1. [P1–059]: APPROACHES TO SUBJECT RETENTION IN A PHASE 3 DELAY‐OF‐ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER's DISEASE (MCI‐AD) CLINICAL TRIAL: THE TOMMORROW STUDY EXPERIENCE. (1st July 2017) Authors: Welsh‐Bohmer, Kathleen A.; Plassman, Brenda L.; Chiang, Carl; Culp, Meredith; Harrigan, Patrick; O'Neil, Janet; Walter, Ryan; Haneline, Stephen; Arbuckle, Julian; Brewster, Shyama; Maruyama, Yuka; Swanson, Tom; Fitzsimmons, Dominic; Atkins, Alexandra S.; Keefe, Richard S.E.; Burns, Daniel K.; Mar... Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A genetic enrichment strategy for delay of onset of Alzheimer's disease clinical trials: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation. (7th December 2020) Authors: Lutz, Michael W.; Burns, Daniel K.; Alexander, Robert; Culp, Meredith; Yarnall, David; Haneline, Stephen; Chiang, Carl; Lai, Eric; Metz, Craig; Sundseth, Scott; Guennel, Tobi; Marshall, Scott; Andruss, Bernard F.; Latham, Gary J.; Hall, Bradley; Statt, Sarah N.; Swanson, Tom; Ratti, Emiliangelo; ... Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 5 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O1–06–01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease. (1st July 2013) Authors: Welsh‐Bohmer, Kathleen; Romero, Heather; Hayden, Kathleen; Plassman, Brenda; Germain, Cassandra; Sano, Mary; Espeland, Mark; Craft, Suzanne; Monsch, Andreas; Schneider, Lon; Chiang, Carl; Haneline, Stephen; Oneil, Janet; Malholtra, Manoj; Brannan, Stephen; Burns, Daniel; Roses, Allen D. Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O4‐11‐02: DEFINING COGNITION IN PRE‐DEMENTIA CLINICAL TRIALS: BASELINE NEUROPSYCHOLOGICAL DATA FROM THE TOMMORROW STUDY. (1st July 2019) Authors: Welsh-Bohmer, Kathleen A.; Atkins, Alexandra S.; Plassman, Brenda L.; Khan, Anzalee; Chiang, Carl; Culp, Meredith; O'Neil, Janet; Walter, Ryan; Haneline, Stephen; Arbuckle, Julian; Brewster, Shyama; Maruyama, Yuka; Swanson, Tom; Hayden, Kathleen M.; Romero, Heather; Keefe, Richard SE.; Saunders, ... Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 24 Page Start: P1262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1‐050: ADJUDICATING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE AS A NOVEL ENDPOINT EVENT IN THE TOMMORROW STUDY: A DELAY‐OF‐ONSET PHASE 3 CLINICAL TRIAL. (1st July 2006) Authors: Chiang, Carl; Alexander, Robert; Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Romero, Heather; Hayden, Kathleen M.; Keefe, Richard SE.; Atkins, Alexandra S.; Harrigan, Patrick; O'Neil, Janet; Culp, Meredith; Walter, Ryan; Wu, Jingtao; Randle, LaDonna; Haneline, Stephen; Yarbrough, Deborah; Met... Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 5 Page Start: P286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4‐383: Characterization of the Screened Population for the Tommorrow Study: a Pharmacogenetics‐Supported Clinical Trial to Delay the Onset of Mild Cognitive Impairment Due to Alzheimer'S Disease. (1st July 2016) Authors: Martenyi, Ferenc; Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Harrigan, Patrick; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Culp, Meredith; Lutz, Michael W.; Lai, Eric; Saunders, Ann M.; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Burns, Daniel K.; Roses, Allen D. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2014)Part 24 Page Start: P1184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Issue 7 (July 2021) Authors: Burns, Daniel K; Alexander, Robert C; Welsh-Bohmer, Kathleen A; Culp, Meredith; Chiang, Carl; O'Neil, Janet; Evans, Rebecca M; Harrigan, Patrick; Plassman, Brenda L; Burke, James R; Wu, Jingtao; Lutz, Michael W; Haneline, Stephen; Schwarz, Adam J; Schneider, Lon S; Yaffe, Kristine; Saunders, Ann ... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial. Issue 1 (1st January 2019) Authors: Burns, Daniel K.; Chiang, Carl; Welsh‐Bohmer, Kathleen A.; Brannan, Stephen K.; Culp, Meredith; O'Neil, Janet; Runyan, Grant; Harrigan, Patrick; Plassman, Brenda L.; Lutz, Michael; Lai, Eric; Haneline, Stephen; Yarnall, David; Yarbrough, Deborah; Metz, Craig; Ponduru, Sridevi; Sundseth, Scott; Sa... Journal: Alzheimer's & dementia Issue: Volume 5:Issue 1(2019) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗